A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease-Reference-Cited by-同舟云学术

A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease

Published:2013-09 Issue:9 Volume:19 Page:1323-1330
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Hansen John A.,Hanash Samir M.,Tabellini Laura,Baik Chris,Lawler Richard L.,Grogan Bryan M.,Storer Barry,Chin Alice,Johnson Melissa,Wong Chee-Hong,Zhang Qing,Martin Paul J.,McDonald George B.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference52 articles.

1. New roles for TIM family members in immune regulation;Kuchroo;Nat Rev Immunol,2008

2. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response;Sehrawat;PLoS Pathog,2010

3. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: Shifting the balance toward regulators;Sehrawat;J Immunol,2009

4. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity;Zhu;Nat Immunol,2005

5. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines;Hastings;Eur J Immunol,2009

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study;Transplant Immunology;2024-08

2. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance;Cell Reports Medicine;2024-08

3. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?;Pharmaceuticals;2024-02-26

4. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants;Frontiers in Immunology;2024-02-16

5. Galectin‐9 alleviates acute graft‐versus‐host disease after haplo‐hematopoietic stem cell transplantation by regulating regulatory T cell/effector T cell imbalance;Immunity, Inflammation and Disease;2024-02